AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Brinker International
EAT
$9.17B
| $2.03M | ﹤0.01% |
81,258
+2,565
| +3% | +$69.3K |
|
1877
Investar Holding Corp
ISTR
$415M
| $2.03M | ﹤0.01% |
101,937
-3,066
| -3% | -$66.8K |
|
1878
Morningstar
MORN
$7.22B
| $2.03M | ﹤0.01% |
9,540
-134
| -1% | -$31.9K |
|
1879
Clarivate
CLVT
$1.27B
| $2.02M | ﹤0.01% |
215,181
+1,605
| +0.8% | +$20.3K |
|
1880
Novartis
NVS
$297B
| $2.02M | ﹤0.01% |
26,567
+554
| +2% | +$45.9K |
|
1881
Coca-Cola Europacific Partners
CCEP
$48.3B
| $2.02M | ﹤0.01% |
47,331
+738
| +2% | +$37.1K |
|
|
ORGN
1882
DELISTED
Origin Materials
ORGN
| $2.01M | ﹤0.01% |
+13,013
| New | +$2.3M |
|
1883
Enovix
ENVX
$892M
| $2.01M | ﹤0.01% |
125,486
| – | – |
|
1884
RE/MAX Holdings
RMAX
$193M
| $2.01M | ﹤0.01% |
106,446
+1,752
| +2% | +$41.6K |
|
|
VBFC
1885
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $2.01M | ﹤0.01% |
45,832
-1
| -0% | -$49 |
|
1886
Axalta
AXTA
$7.66B
| $2M | ﹤0.01% |
95,198
-434
| -0.5% | -$10.7K |
|
|
VISN
1887
Vistance Networks Inc
VISN
$2.65B
| $2M | ﹤0.01% |
217,466
+236
| +0.1% | +$2.26K |
|
|
OSH
1888
DELISTED
Oak Street Health, Inc.
OSH
| $2M | ﹤0.01% |
81,615
+34,713
| +74% | +$918K |
|
1889
Orthofix Medical
OFIX
$477M
| $2M | ﹤0.01% |
104,458
+39
| +0% | +$877 |
|
1890
CorVel
CRVL
$3.06B
| $1.99M | ﹤0.01% |
43,059
+393
| +0.9% | +$20.4K |
|
|
CPRX
1891
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.99M | ﹤0.01% |
154,699
-363,012
| -70% | -$4.3M |
|
1892
Methode Electronics
MEI
$496M
| $1.99M | ﹤0.01% |
53,426
+54
| +0.1% | +$2.11K |
|
|
NVEE
1893
DELISTED
NV5 Global
NVEE
| $1.98M | ﹤0.01% |
64,016
-19,332
| -23% | -$632K |
|
1894
Under Armour
UAA
$2.84B
| $1.98M | ﹤0.01% |
296,925
-31,329
| -10% | -$274K |
|
1895
Acadia Realty Trust
AKR
$3.09B
| $1.97M | ﹤0.01% |
155,955
-6,356
| -4% | -$102K |
|
1896
Franco-Nevada
FNV
$41.1B
| $1.96M | ﹤0.01% |
16,369
-7,116
| -30% | -$895K |
|
1897
Logitech
LOGI
$14.7B
| $1.96M | ﹤0.01% |
42,530
+559
| +1% | +$29.4K |
|
1898
Cheesecake Factory
CAKE
$5.04B
| $1.95M | ﹤0.01% |
66,582
-12
| -0% | -$364 |
|
1899
Vale
VALE
$64.1B
| $1.95M | ﹤0.01% |
146,377
-215,647
| -60% | -$2.84M |
|
|
RNAM
1900
DELISTED
Avidity Biosciences
RNAM
| $1.95M | ﹤0.01% |
119,366
-152,923
| -56% | -$2.93M |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.